D
Deborah P. Saunders
Researcher at Northern Ontario School of Medicine
Publications - 35
Citations - 2945
Deborah P. Saunders is an academic researcher from Northern Ontario School of Medicine. The author has contributed to research in topics: Cancer & Mucositis. The author has an hindex of 15, co-authored 30 publications receiving 2130 citations. Previous affiliations of Deborah P. Saunders include Health Sciences North.
Papers
More filters
Journal ArticleDOI
Smoking Cessation in Cancer Care: Myths, Presumptions and Implications for Practice.
Meredith Giuliani,Meredith Giuliani,Janette Brual,E. Cameron,Michael Chaiton,Lawson Eng,M. Haque,Geoffrey Liu,Nicole Mittmann,Janet Papadakos,Deborah P. Saunders,Rebecca Truscott,William K. Evans +12 more
Journal ArticleDOI
MASCC/ISOO expert opinion on the management of oral problems in patients with advanced cancer
Jac A.R. Jones,Yanin Chavarri-Guerra,Luisa Barreto Costa Corrêa,David R. Dean,Joel B. Epstein,Eduardo Rodrigues Fregnani,Jiyeon Lee,Yuhei Matsuda,Valeria Mercadante,Ragnhild Elisabeth Monsen,Natasja J. H. Rajimakers,Deborah P. Saunders,Enrique Soto-Perez-de-Celis,Mariana S. Sousa,Arghavan Tonkaboni,Arjan Vissink,Keng Soon Yeoh,A. Davies +17 more
TL;DR: The Palliative Care Study Group in conjunction with the oral care study group of the Multinational Association for Supportive Care in Cancer (MASCC) formed a sub-group to develop evidence-based guidance on the management of common oral problems in patients with advanced cancer as discussed by the authors .
Journal ArticleDOI
Results of a randomized, placebo (PBO) controlled, double-blind P2b trial of GC4419 (avisopasem manganese) to reduce duration, incidence and severity and delay onset of severe radiation-related oral mucositis (SOM) in patients (pts) with locally advanced squamous cell cancer of the oral cavity (OC) or oropharynx (OP).
Carryn M. Anderson,Christopher M. Lee,Deborah P. Saunders,Amarinthia Curtis,Neal Dunlap,Chaitali Singh Nangia,Arielle Shebay Lee,Jon Holmlund,Jeffrey Mark Brill,Stephen T. Sonis,John M. Buatti +10 more
TL;DR: In this article, intensity-modulated radiotherapy (IMRT) plus cisplatin was used for locally advanced OC/OP cancer, but only 70% of patients developed SOM, defined as WHO Grade 3 or 4.
Journal ArticleDOI
Rates of Smoking Cessation at 6 and 12 Months after a Clinical Tobacco Smoking Cessation Intervention in Head and Neck Cancer Patients in Northern Ontario, Canada
Stacey A. Santi,Michael Conlon,Margaret L. Meigs,S M Davidson,Kyle Mispel-Beyer,Deborah P. Saunders +5 more
TL;DR: Although the head and neck cancer patients in this study reported high levels of nicotine dependence, many were able to successfully cessate, and it took those who were smoking 1–5 attempts to quit, but once they quit they remained cessated for the duration of the study.
Journal ArticleDOI
Effects of GC4419 (avasopasem manganese) on chronic kidney disease in head and neck cancer patients treated with radiation and cisplatin.
Emily J. Steinbach,Varun Monga,Muhammad Furqan,Douglas Earl Laux,Diana Zepeda-Orozco,Jennifer G. Jetton,Deborah P. Saunders,Neal Dunlap,Amarinthia Curtis,Robert Fairbanks,Sarah Bell,Carryn M. Anderson,Robert A. Beardsley,Jon Holmlund,Douglas R. Spitz,Bryan G. Allen +15 more
TL;DR: This data indicates that continued use of platinum-based chemotherapeutics for long-term renal protection after second-line treatment with chemotherapy results in down-regulation of nephrotoxicity and the prognosis for these patients is good.